ShapeTX is a brand that is revolutionizing the field of programmable RNA medicine. Backed by a strong foundation in science and driven by data, ShapeTX utilizes the power of artificial intelligence (AI) to analyze massive datasets and make intelligent decisions. By combining breakthroughs in AI, RNA technology, and synthetic biology, ShapeTX creates safe, effective, and accessible medicines to benefit as many patients as possible.

The ShapeTX platform focuses on RNA as Medicines, utilizing the therapeutic potential of RNA to redirect cellular machinery and address the underlying causes of various diseases. Through the use of AI and RNA technology, ShapeTX discovers and designs new medicines that are not only effective but also safe and easy to manufacture. The platform offers a range of innovative products, including RNAfix®, which corrects the body's protein-making instructions, RNAskip®, which targets premature stop codons, and RNAswap TM, which tailors gene expression for each gene and target cell type.

ShapeTX also excels in precise delivery, using AI-driven engineering to ensure targeted delivery of RNA medicine while minimizing harm to other parts of the body. ShapeTX is at the forefront of the future of medicine, combining cutting-edge technology with a commitment to improving patient outcomes and accessibility